Hawaii HB2225 regulates prescription drug pricing and reimbursement for pharmacies by pharmacy benefit managers.
Hawaii HB2225 amends state statutes to regulate prescription drug pricing and reimbursement for pharmacies by pharmacy benefit managers. Effective July 1, 2027, all prescription drug benefit plans must use pass-through pricing unless the pharmacy's cost is less than the wholesale acquisition cost. Pharmacy benefit managers must also reimburse pharmacies at least the national average drug acquisition cost and a professional dispensing fee. The bill prohibits pharmacy benefit managers from reimbursing pharmacies below cost and from discriminating against pharmacies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.